Poor outcomes after acute myocardial infarction in systemic lupus erythematosus

Journal of Rheumatology

Volumn 36, Issue 3, 2009, Pages 570-575

  Shah, Mansi A ^a   Shah, Amber M ^a   Krishnan, Eswar ^b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Acute myocardial infarction; Diabetes mellitus; Length of hospital stay; Mortality; Systemic lupus erythematosus

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ETHNICITY; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE; SEX DIFFERENTIATION; SOCIAL STATUS; SYSTEMIC LUPUS ERYTHEMATOSUS; AFRICAN AMERICAN; CASE CONTROL STUDY; CAUCASIAN; ETHNOLOGY; HEART INFARCTION; HISPANIC; LENGTH OF STAY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK; SEX RATIO; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; SEX DISTRIBUTION; UNITED STATES;

EID: 65649090611     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080373     Document Type: Article

References (43)

1. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001;13:345-351 (Pubitemid 32929862)
2. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-2337 (Pubitemid 32977500)
3. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-225
4. Homcy CJ, Liberthson RR, Fallon JT, Gross S, Miller LM. Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases. Am J Cardiol 1982;49:478-484 (Pubitemid 14213454)
5. Petri M, Spence D, Bone LR, Hochberg MC. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine Baltimore 1992;71:291-302.
6. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-415 (Pubitemid 27084212)
7. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:338-346 (Pubitemid 29072852)
8. Thorburn CM, Ward MM. Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus. Arthritis Rheum 2003;48:2519-2523 (Pubitemid 37129429)
9. Ward MM. Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus. Arthritis Rheum 2004;50:3170-3176 (Pubitemid 39371993)
10. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-2406 (Pubitemid 37542988)
11. Pincus T, Gibofsky A, Weinblatt ME. Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum 2002;46:851-854 (Pubitemid 34303793)
12. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:51-60. (Pubitemid 29042570)
13. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126 (Pubitemid 29054847)
14. Hahn BH. Systemic lupus erythematosus and accelerated atherosclerosis. N Engl J Med 2003;349:2379-2380 (Pubitemid 37542984)
15. Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 1988;62:665-669 (Pubitemid 18237116)
16. Jaffe AS, Spadaro JJ, Schechtman K, Roberts R, Geltman EM, Sobel BE. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 1984;108:31-37 (Pubitemid 14087965)
17. Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: an overview. Eff Clin Pract 2002;5:143-151
18. HCIA Inc. The International classification of diseases, 9th revision, Clinical modification: ICD-9-CM administrative databases. 10th ed. Baltimore: HCIA Inc.; 1993.
19. Hart AC, Hopkins C. ICD-9 CM Professional for physicians. 6th ed. Salt Lake City, UT: Ingenix; 2004.
20. Thomas AJ, Eberly LE, Davey Smith G, Neaton JD. ZIP-code-based versus tract-based income measures as long-term risk-adjusted mortality predictors. Am J Epidemiol 2006;164:586-590 (Pubitemid 44412787)
21. Cox DR. Regression models and life tables. JRSS 1972;34:187-220.
22. Woodfield SL, Lundergan CF, Reiner JS, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1996;28:1661-1669 (Pubitemid 26426217)
23. Otter W, Kleybrink S, Doering W, Standl E, Schnell O. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabet Med 2004;21:183-187 (Pubitemid 38221819)
24. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979 (Pubitemid 27152782)
25. Ettinger WH, Goldberg AP, Applebaum-Bowden D, Hazzard WR. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. Am J Med 1987;83:503-508 (Pubitemid 18109911)
26. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-519
27. Vaarala O, Manttari M, Manninen V, et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995;91:23-27
28. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-795 (Pubitemid 24283962)
29. Bittner V. Atherosclerosis and the immune system. Arch Intern Med 1998;158:1395-1396
30. Niculescu F, Rus H. Atherosclerosis and the immune system [letter]. Arch Intern Med 1999;159:315.
31. Sumino H, Kanda T, Sasaki T, Kanazawa N, Takeuchi H. Myocardial infarction secondary to coronary aneurysm in systemic lupus erythematosus. An autopsy case. Angiology 1995;46:527-530
32. Bonfiglio TA, Botti RE, Hagstrom JW. Coronary arteritis, occlusion, and myocardial infarction due to lupus erythematosus. Am Heart J 1972;83:153-158
33. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809 (Pubitemid 23132154)
34. El-Magadmi M, Bodill H, Ahmad Y, et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004;110:399-404. (Pubitemid 38993848)
35. Pullmann R Jr, Skerenova M, Lukac J, et al. Factor V Leiden and prothrombin G20210A mutations and the risk of atherothrombotic events in systemic lupus erythematosus. Clin Appl Thromb Hemost 2004;10:233-238 (Pubitemid 38982047)
36. Giugliano GR, Giugliano RP, Gibson CM, Kuntz RE. Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol 2003;91:1055-1059 (Pubitemid 36514919)
37. Gerstein HC, Thorpe KE, Taylor DW, Haynes RB. The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas - a randomized trial. Diabetes Res Clin Pract 2002;55:209-219 (Pubitemid 34163292)
38. Petri M, Lakatta C, Magder L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994;96:254-259 (Pubitemid 24099225)
39. Wallace DJ, Metzger AL, Stecher VJ, Turnbull BA, Kern PA. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med 1990;89:322-326 (Pubitemid 20323259)
40. Green J, Wintfeld N. How accurate are hospital discharge data for evaluating effectiveness of care? Med Care 1993;31:719-731
41. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care 1994;32:81-90.
42. Costenbader KH, Wright E, Liang MH, Karlson EW. Cardiac risk factor awareness and management in patients with systemic lupus erythematosus. Arthritis Rheum 2004;51:983-988 (Pubitemid 39648192)
43. Nikpour M, Urowitz MB, Gladman DD. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2005;31:329-354, vii-viii. (Pubitemid 40732492)